These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 23479173)
1. Parallel proteomic analysis in muscle-invasive bladder transitional cell carcinoma and cancer-related stroma. Niu HT; Qi XJ; Liu YQ; Cao YW; Dong Q; Wang XS Genet Mol Res; 2013 Feb; 12(4):4251-63. PubMed ID: 23479173 [TBL] [Abstract][Full Text] [Related]
2. Biomarker research and some deduction in superficial bladder cancer cells combined with corresponding stroma. Niu HT; Yang CM; Chen B; Dong Q Cancer Biomark; 2011-2012; 10(2):109-16. PubMed ID: 22430138 [TBL] [Abstract][Full Text] [Related]
3. Far from resolved: stromal cell-based iTRAQ research of muscle-invasive bladder cancer regarding heterogeneity. Liu PF; Wang YH; Cao YW; Jiang HP; Yang XC; Wang XS; Niu HT Oncol Rep; 2014 Oct; 32(4):1489-96. PubMed ID: 25050759 [TBL] [Abstract][Full Text] [Related]
4. Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery. Niu HT; Yang CM; Jiang G; Xu T; Cao YW; Zhao J; Wang XS J Cancer Res Clin Oncol; 2011 Aug; 137(8):1273-82. PubMed ID: 21706132 [TBL] [Abstract][Full Text] [Related]
5. Differences in shotgun protein expression profile between superficial bladder transitional cell carcinoma and normal urothelium. Niu HT; Zhang YB; Jiang HP; Cheng B; Sun G; Wang Y; E YJ; Pang de Q; Chang JW Urol Oncol; 2009; 27(4):400-6. PubMed ID: 18818109 [TBL] [Abstract][Full Text] [Related]
6. Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis. Yang MH; Chu PY; Chen SC; Chung TW; Chen WC; Tan LB; Kan WC; Wang HY; Su SB; Tyan YC Biochem Biophys Res Commun; 2011 Aug; 411(4):714-20. PubMed ID: 21782798 [TBL] [Abstract][Full Text] [Related]
7. Stromal proteome expression profile and muscle-invasive bladder cancer research. Niu H; Jiang H; Cheng B; Li X; Dong Q; Shao L; Liu S; Wang X Cancer Cell Int; 2012 Aug; 12(1):39. PubMed ID: 22920603 [TBL] [Abstract][Full Text] [Related]
8. Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis. Tolson JP; Flad T; Gnau V; Dihazi H; Hennenlotter J; Beck A; Mueller GA; Kuczyk M; Mueller CA Proteomics; 2006 Jan; 6(2):697-708. PubMed ID: 16252305 [TBL] [Abstract][Full Text] [Related]
9. Shotgun proteome expression profile of microdissected superficial transitional cell carcinoma and biomarker discovery from urine. Niu HT; Li SJ; Xu T; Yu QC; Chang JW; Sun G Mol Med Rep; 2009; 2(5):719-23. PubMed ID: 21475891 [TBL] [Abstract][Full Text] [Related]
10. Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma. Paterson RF; Ulbright TM; MacLennan GT; Zhang S; Pan CX; Sweeney CJ; Moore CR; Foster RS; Koch MO; Eble JN; Cheng L Cancer; 2003 Nov; 98(9):1830-6. PubMed ID: 14584063 [TBL] [Abstract][Full Text] [Related]
11. Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis. Liu PF; Cao YW; Jiang HP; Wang YH; Yang XC; Wang XS; Niu HT Med Oncol; 2014 Sep; 31(9):21. PubMed ID: 25085780 [TBL] [Abstract][Full Text] [Related]
12. Expression profile of microrna-145 in urothelial bladder cancer. Dip N; Reis ST; Srougi M; Dall'Oglio MF; Leite KR Int Braz J Urol; 2013; 39(1):95-101; discussion 102. PubMed ID: 23489501 [TBL] [Abstract][Full Text] [Related]
13. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture. Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871 [TBL] [Abstract][Full Text] [Related]
14. Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of Survival. von Rundstedt FC; Rajapakshe K; Ma J; Arnold JM; Gohlke J; Putluri V; Krishnapuram R; Piyarathna DB; Lotan Y; Gödde D; Roth S; Störkel S; Levitt JM; Michailidis G; Sreekumar A; Lerner SP; Coarfa C; Putluri N J Urol; 2016 Jun; 195(6):1911-9. PubMed ID: 26802582 [TBL] [Abstract][Full Text] [Related]
15. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [TBL] [Abstract][Full Text] [Related]
16. Proteomics research on muscle-invasive bladder transitional cell carcinoma. Niu HT; Dong Z; Jiang G; Xu T; Liu YQ; Cao YW; Zhao J; Wang XS Cancer Cell Int; 2011 Jun; 11(1):17. PubMed ID: 21645413 [TBL] [Abstract][Full Text] [Related]
17. Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini. Chastain EC; Oliva IV; Osunkoya AO Pathology; 2012 Apr; 44(3):199-203. PubMed ID: 22406481 [TBL] [Abstract][Full Text] [Related]
18. Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis. Sheng KH; Yao YC; Chuang SS; Wu H; Wu TF Proteomics; 2006 Feb; 6(3):1058-65. PubMed ID: 16400682 [TBL] [Abstract][Full Text] [Related]
19. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder. Han Y; Liu Y; Gui Y; Cai Z J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726 [TBL] [Abstract][Full Text] [Related]
20. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness. Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]